Global Insulin Market Size study, by Product (Rapid-Acting Insulin, Long-Acting Insulin, Combination Insulin, Biosimilar, Others) by Application (Human Insulin, Insulin Analog), by Type (Type 1, Type 2), by Distribution Channel (Hospitals, Retail Pharmacies, Others) and Regional Forecasts 2022-2028
- BIZ4983523
- 200 Pages
- July 2022
- Pharmaceuticals
The key regions considered for the Global Insulin Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the space in terms of revenue in 2021, owing to the dominance of branded products and the region's increasing disease prevalence. According to the CDC, there will be roughly 37.3 million diabetics in the United States in 2020, including 28.7 million diagnosed and 8.5 million undiagnosed cases. Asia Pacific is expected to grow significantly during the forecast period, owing to factors such as rising geriatric and target populations, an increase in the number of collaborations for biosimilar development, geographic expansion of key players, and active participation of government and nonprofit organizations in the market space.
Major market player included in this report are:
Novo Nordisk A/S
Eli Lilly and Company
Sanofi
Biocon Ltd
Wockhardt
Boehringer Ingelheim International GmbH
Julphar
United Laboratories International Holdings Limited
Tonghua Dongbao Pharmaceutical Co. Ltd.
Pfizer
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product:
Rapid-Acting Insulin
Long-Acting Insulin
Combination Insulin
Biosimilar
Others
By Type:
Type 1 Diabetes Mellitus
Type 2 Diabetes Mellitus
By Application:
Human Insulin
Insulin Analog
By Distribution Channel:
Hospitals
Retail Pharmacies
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028
Target Audience of the Global Insulin Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
1.2.1. Insulin Market, by Region, 2020-2028 (USD Billion)
1.2.2. Insulin Market, by Product, 2020-2028 (USD Billion)
1.2.3. Insulin Market, by Type, 2020-2028 (USD Billion)
1.2.4. Insulin Market, by Application, 2020-2028 (USD Billion)
1.2.5. Insulin Market, by Distribution Channel, 2020-2028 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Insulin Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Insulin Market Dynamics
3.1. Insulin Market Impact Analysis (2020-2028)
3.1.1. Market Drivers
3.1.1.1. Increasing incidence of diabetes
3.1.1.2. Growing gGeriatric pPopulation
3.1.2. Market Challenges
3.1.2.1. High cCost of Insulin
3.1.3. Market Opportunities
3.1.3.1. Advancements in fFormulation
Chapter 4. Global Insulin Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2028)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Insulin Market, by Product
6.1. Market Snapshot
6.2. Global Insulin Market by Product, Performance - Potential Analysis
6.3. Global Insulin Market Estimates & Forecasts by Product 2018-2028 (USD Billion)
6.4. Insulin Market, Sub Segment Analysis
6.4.1. Rapid-Acting Insulin
6.4.2. Long-Acting Insulin
6.4.3. Combination Insulin
6.4.4. Biosimilar
6.4.5. Others
Chapter 7. Global Insulin Market, by Type
7.1. Market Snapshot
7.2. Global Insulin Market by Type, Performance - Potential Analysis
7.3. Global Insulin Market Estimates & Forecasts by Type 2018-2028 (USD Billion)
7.4. Insulin Market, Sub Segment Analysis
7.4.1. Type 1 Diabetes Mellitus
7.4.2. Type 2 Diabetes Mellitus
Chapter 8. Global Insulin Market, by Application
8.1. Market Snapshot
8.2. Global Insulin Market by Application, Performance - Potential Analysis
8.3. Global Insulin Market Estimates & Forecasts by Application 2018-2028 (USD Billion)
8.4. Insulin Market, Sub Segment Analysis
8.4.1. Human Insulin
8.4.2. Insulin Analog
Chapter 9. Global Insulin Market, by Distribution Channel
9.1. Market Snapshot
9.2. Global Insulin Market by Distribution Channel, Performance - Potential Analysis
9.3. Global Insulin Market Estimates & Forecasts by Distribution Channel 2018-2028 (USD Billion)
9.4. Insulin Market, Sub Segment Analysis
9.4.1. Hospitals
9.4.2. Retail Pharmacies
9.4.3. Others
Chapter 10. Global Insulin Market, Regional Analysis
10.1. Insulin Market, Regional Market Snapshot
10.2. North America Insulin Market
10.2.1. U.S. Insulin Market
10.2.1.1. Product breakdown estimates & forecasts, 2018-2028
10.2.1.2. Type breakdown estimates & forecasts, 2018-2028
10.2.1.3. Application breakdown estimates & forecasts, 2018-2028
10.2.1.4. Distribution Channel breakdown estimates & forecasts, 2018-2028
10.2.2. Canada Insulin Market
10.3. Europe Insulin Market Snapshot
10.3.1. U.K. Insulin Market
10.3.2. Germany Insulin Market
10.3.3. France Insulin Market
10.3.4. Spain Insulin Market
10.3.5. Italy Insulin Market
10.3.6. Rest of Europe Insulin Market
10.4. Asia-Pacific Insulin Market Snapshot
10.4.1. China Insulin Market
10.4.2. India Insulin Market
10.4.3. Japan Insulin Market
10.4.4. Australia Insulin Market
10.4.5. South Korea Insulin Market
10.4.6. Rest of Asia Pacific Insulin Market
10.5. Latin America Insulin Market Snapshot
10.5.1. Brazil Insulin Market
10.5.2. Mexico Insulin Market
10.6. Rest of The World Insulin Market
Chapter 11. Competitive Intelligence
11.1. Top Market Strategies
11.2. Company Profiles
11.2.1. Novo Nordisk A/S
11.2.1.1. Key Information
11.2.1.2. Overview
11.2.1.3. Financial (Subject to Data Availability)
11.2.1.4. Product Summary
11.2.1.5. Recent Developments
11.2.2. Eli Lilly and Company
11.2.3. Sanofi
11.2.4. Biocon Ltd
11.2.5. Wockhardt
11.2.6. Boehringer Ingelheim International GmbH
11.2.7. Julphar
11.2.8. United Laboratories International Holdings Limited
11.2.9. Tonghua Dongbao Pharmaceutical Co. Ltd.
11.2.10. Pfizer
Chapter 12. Research Process
12.1. Research Process
12.1.1. Data Mining
12.1.2. Analysis
12.1.3. Market Estimation
12.1.4. Validation
12.1.5. Publishing
12.2. Research Attributes
12.3. Research Assumption
TABLE 1. Global Insulin Market, report scope
TABLE 2. Global Insulin Market estimates & forecasts by Region 2018-2028 (USD Billion)
TABLE 3. Global Insulin Market estimates & forecasts by Product 2018-2028 (USD Billion)
TABLE 4. Global Insulin Market estimates & forecasts by Type 2018-2028 (USD Billion)
TABLE 5. Global Insulin Market estimates & forecasts by Application 2018-2028 (USD Billion)
TABLE 6. Global Insulin Market estimates & forecasts by Distribution Channel 2018-2028 (USD Billion)
TABLE 7. Global Insulin Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 8. Global Insulin Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 9. Global Insulin Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 10. Global Insulin Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 11. Global Insulin Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 12. Global Insulin Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 13. Global Insulin Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 14. Global Insulin Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 15. Global Insulin Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 16. Global Insulin Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 17. U.S. Insulin Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 18. U.S. Insulin Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 19. U.S. Insulin Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 20. Canada Insulin Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 21. Canada Insulin Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 22. Canada Insulin Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 23. UK Insulin Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 24. UK Insulin Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 25. UK Insulin Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 26. Germany Insulin Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 27. Germany Insulin Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 28. Germany Insulin Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 29. RoE Insulin Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 30. RoE Insulin Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 31. RoE Insulin Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 32. China Insulin Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 33. China Insulin Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 34. China Insulin Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 35. India Insulin Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 36. India Insulin Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 37. India Insulin Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 38. Japan Insulin Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 39. Japan Insulin Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 40. Japan Insulin Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 41. RoAPAC Insulin Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 42. RoAPAC Insulin Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 43. RoAPAC Insulin Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 44. Brazil Insulin Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 45. Brazil Insulin Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 46. Brazil Insulin Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 47. Mexico Insulin Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 48. Mexico Insulin Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 49. Mexico Insulin Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 50. RoLA Insulin Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 51. RoLA Insulin Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 52. RoLA Insulin Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 53. Row Insulin Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 54. Row Insulin Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 55. Row Insulin Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 56. List of secondary sources, used in the study of global Insulin Market
TABLE 57. List of primary sources, used in the study of global Insulin Market
TABLE 58. Years considered for the study
TABLE 59. Exchange rates considered
Similar Reports
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
- Publish Date: November 14, 2017
- $5370
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
- Publish Date: July 20, 2017
- $5370
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...
- Publish Date: April 24, 2017
- $5370
